This post was originally published on this site
https://content.fortune.com/wp-content/uploads/2022/07/GettyImages-1292997730-e1658804672814.jpg
China just approved its first domestic anti-COVID pill, Azvudine, and is ready to produce 6.8 billion pills a year at half the price of Pfizer’s Paxlovid
3 years ago
No Comments
Related Posts
Apple, Honda, and Mazda reportedly consider diversifying manufacturing away from China after supply chain chaos
August 25, 2022
Founder Adam Neumann explains why Marc Andreessen invested $350 million in Flow, his new company that sounds a lot like WeWork
July 14, 2023
How to close the gender investing confidence gap
December 17, 2020
Parents of Children With Diabetes Are Furious Following the Blackout of a Major Blood Sugar Monitoring Software
December 2, 2019
Elon Musk says Twitter’s ideal market isn’t the U.S.—it’s Japan
November 23, 2022
Need to entertain your kids? These educational apps may help
September 13, 2020
About The Author
